Breaking News Instant updates and real-time market news.

SBUX

Starbucks

$54.52

-1.11 (-2.00%)

, ALB

Albemarle

$113.28

-2.13 (-1.85%)

10:39
08/09/17
08/09
10:39
08/09/17
10:39

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Starbucks (SBUX) downgraded on more cautious U.S. comp sales outlook at BMO Capital with analyst Andrew Strelzik saying he's "more cautious" on the outlook for the company's U.S. comparable sales, partly due to increased cannibalization of stores, increased competition, "throughput headwinds," and the possibility that "contributions from beverage innovation and food growth may have peaked." 2. Albemarle (ALB) downgraded to Hold from Buy at SunTrust with analyst James Sheehan citing recent share strength. 3. Dean Foods (DF) downgraded to Market Perform from Outperform at Wells Fargo with analyst John Baumgartnerm citing the second quarter miss and "big" guidance reduction. 4. Air Lease (AL) downgraded to Neutral from Buy at BofA/Merrill with analyst Kristine Liwag citing valuation. 5. AIG (AIG) downgraded to Neutral from Overweight at Atlantic Equities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

SBUX

Starbucks

$54.52

-1.11 (-2.00%)

ALB

Albemarle

$113.28

-2.13 (-1.85%)

DF

Dean Foods

$12.00

0.135 (1.14%)

AL

Air Lease

$41.17

-1.3196 (-3.11%)

AIG

AIG

$63.99

-0.58 (-0.90%)

  • 23

    Aug

  • 02

    Nov

  • 25

    Jan

SBUX Starbucks
$54.52

-1.11 (-2.00%)

08/09/17
BMOC
08/09/17
DOWNGRADE
BMOC
Market Perform
Starbucks downgraded on more cautious U.S. comp sales outlook at BMO Capital
As noted earlier, BMO Capital downgraded Starbucks to Market Perform from Outperform. Analyst Andrew Strelzik says he's "more cautious" on the outlook for the company's U.S. comp sales, partly due to increased cannibalization of stores, increased competition, "throughput headwinds," and the possibility that "contributions from beverage innovation and food growth may have peaked."
08/09/17
BMOC
08/09/17
DOWNGRADE
BMOC
Market Perform
Starbucks downgraded to Market Perform from Outperform at BMO Capital
07/28/17
07/28/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Starbucks (SBUX) was downgraded to Neutral from Buy at Guggenheim and to Hold from Buy at Stifel. 2. Spirit Airlines (SAVE) was downgraded to Neutral from Buy at Buckingham and BofA/Merrill and to In-Line from Outperform at Imperial Capital. 3. Flowers Foods (FLO) downgraded to Hold from Buy at Jefferies with analyst Akshay Jagdale saying his positive thesis on bread industry pricing becoming more rational has not played out. 4. AstraZeneca (AZN) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Vincent Meunier saying shares look fairly valued as he removed MYSTIC from his models. 5. U.S. Steel (X) downgraded to Sell from Neutral at Citi with analyst Alexander Hacking saying he sees downside risk to U.S. flat rolled prices for the remainder of 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/28/17
JPMS
07/28/17
NO CHANGE
Target $62
JPMS
Overweight
Starbucks nearing sub-$55 level JPMorgan's been waiting for
JPMorgan analyst John Ivanko says Starbucks is now approaching the sub-$55 per share level he's been waiting for. The stock in premarket trading is down $3.93 to $55.57 following last night's Q3 earnings report. He believes the company's 15%-20% five-year earnings growth rate given in December 2016 is being re-evaluated with any revisions coming on the Q4 earnings release. The analyst sees the "reasonable" earnings growth rate as 10%-15%. Ivanko trimmed his price target for the shares to $62 from $63 and keeps an Overweight rating on Starbucks.
ALB Albemarle
$113.28

-2.13 (-1.85%)

08/04/17
AGIS
08/04/17
NO CHANGE
Target $125
AGIS
Buy
Albemarle pullback on weather issues would be a buying opportunity, says Aegis
Aegis analyst Chris Kapsch believes media reports suggesting Albemarle's lithium production in Chile may have been disrupted by extreme weather in early June "could prove credible," but he thinks any pullback if the company acknowledges any weather-related production disruption would be a buying opportunity given EV adoption may be accelerating and there are projections for lithium prices to likely increase in both 2018 and 2019. Kapsch has a Buy rating and $125 price target on Albemarle ahead of its Q2 report next week.
08/09/17
RHCO
08/09/17
DOWNGRADE
Target $121
RHCO
Hold
Albemarle downgraded to Hold from Buy at SunTrust
SunTrust analyst James Sheehan downgraded Albemarle to Hold with a $121 price target citing recent share strength.
08/09/17
BARD
08/09/17
NO CHANGE
Target $135
BARD
Outperform
Albemarle still best positioned to benefit from lithium demand, says Baird
Baird analyst Ben Kallo noted Albermarle management reiterated 2017 guidance and still expects the lithium market to grow in excess of 35% year over year. The analyst noted capacity expansion efforts remain on track and favorable market conditions should contribute to a solid second half 2017. He recommends investors buy the shares after the post-earnings downward pressure subsides. Kallo reiterated his Buy rating and $135 price target on Albermarle shares.
08/09/17
RBCM
08/09/17
NO CHANGE
RBCM
Albemarle should be bought on weakness, says RBC Capital
RBC Capital analyst Arun Viswanathan says Albermarle bulls were probably disappointed by the company's failure to raise its guidance. However, the analyst thinks that the company's pricing power should be boosted into 2018 by "favorable lithium supply/demand dynamics." He recommends buying the stock on weakness.
DF Dean Foods
$12.00

0.135 (1.14%)

08/08/17
JPMS
08/08/17
DOWNGRADE
Target $12
JPMS
Neutral
Dean Foods downgraded to Neutral with $12 target at JPMorgan
JPMorgan analyst Ken Goldman downgraded Dean Foods to Neutral from Overweight and cut his price target for the shares to $12 from $22 following the company's weaker than expected Q2 results. The analyst attributes the results to competitive and macro pressures. Stephens also downgraded the shares today post-earnings.
08/08/17
08/08/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Dean Foods (DF) was downgraded to Neutral from Overweight at JPMorgan and to Equal Weight from Overweight at Stephens. 2. Armstrong Flooring (AFI) downgraded to Hold from Buy at Gabelli. 3. Plains All American (PAA) was downgraded to Neutral from Outperform at Baird and to Sector Perform at Scotia Howard Weil. 4. Beazer Homes (BZH) downgraded to Neutral from Outperform at Wedbush with analyst Jay McCanless citing valuation and lack of near-term catalysts. 5. Noble Corp. (NE) downgraded to Hold from Buy at Societe Generale with analyst Edward Muztafago saying the weak pricing environment will limit near-term improvement in the deepwater market and believes it will be second half 2018, at the earliest, before new project work picks up more materially. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/08/17
VERT
08/08/17
DOWNGRADE
VERT
Hold
Dean Foods downgraded to Hold from Buy at Vertical Research
08/09/17
WELS
08/09/17
DOWNGRADE
Target $12
WELS
Market Perform
Dean Foods downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst John Baumgartnerm downgraded Dean Foods to Market Perform and cut his price target for the shares to $12 from $25 citing the Q2 miss and "big" guidance reduction. The analyst needs more visibility on margins before viewing Dean as a value story. He adds that a takeout by a strategic buyer "could be possible."
AL Air Lease
$41.17

-1.3196 (-3.11%)

01/04/17
COMP
01/04/17
INITIATION
Target $46
COMP
Buy
Air Lease initiated with a Buy at Compass Point
Compass Point analyst Scott Valentin initiated Air Lease with a Neutral and a $46 price target due to high level of earnings visibility given the robust order book and high percentage of future deliveries placed, high level of profitability as evidenced by strong profit margin and relatively high ROE, and is best positioned among lessors to benefit from a reduction in the corporate tax rate.
04/06/17
MSCO
04/06/17
DOWNGRADE
MSCO
Equal Weight
Air Lease downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Rajeev Lalwani downgraded Air Lease to Equal Weight and raised his price target to $42 from $40 telling investors shares have had a solid run and faces headwinds from peaking airline profits and order activity.
07/10/17
LEHM
07/10/17
INITIATION
Target $48
LEHM
Overweight
Air Lease initiated with an Overweight at Barclays
Barclays analyst Mark DeVries started Air Lease with an Overweight rating and $48 price target. The analyst views the air lessors as "relatively ignored" but attractive investments. It is hard to find lending stocks that consistently generate low to mid-teen cash return on equity but trade at or below book value, the analyst contends.
08/09/17
BOFA
08/09/17
DOWNGRADE
Target $44
BOFA
Neutral
Air Lease downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Kristine Liwag downgraded Air Lease to Neutral on valuation and maintained a $44 price target.
AIG AIG
$63.99

-0.58 (-0.90%)

08/09/17
ATLE
08/09/17
DOWNGRADE
ATLE
Neutral
AIG downgraded to Neutral from Overweight at Atlantic Equities
07/05/17
DBAB
07/05/17
NO CHANGE
Target $57
DBAB
Sell
AIG Q2 results could be negative catalyst, says Deutsche Bank
Deutsche Bank analyst Joshua Shanker recommends investors consider that AIG's earnings results could be a negative catalyst. The analyst advises investor caution saying the company faces difficult year-ago comparables. He also believes the new CEO "will have no reason to paint the numbers as any better than they are." Shanker has a Sell rating on AIG with a $57 price target.
05/16/17
05/16/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AIG (AIG) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Kai Pan citing the "strong" new Chief Executive Officer and attractive valuation. 2. Yum! Brands (YUM) upgraded to Buy from Hold at Argus with analyst John Staszak citing the company's decision to refranchise an additional 5% of its stores and institute additional cost cutting measures as reasons for the upgrade. 3. Dr Pepper Snapple (DPS) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Dara Mohsenian saying the company's organic sales growth is accelerating driven by an improved competitive outlook as Coca Cola (KO) and Pepsi (PEP) focus on using cash flow from the U.S. carbonated soft drink segment in high growth areas. 4. Regal Entertainment (RGC) upgraded to Buy from Hold at Loop Capital with analyst David Millerciting recent weakness in shares and has confidence the company will pay a special dividend to shareholders around the fourth quarter or in the first half of 2018. 5. Vipshop (VIPS) upgraded to Overweight from Neutral at JPMorgan. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/16/17
MSCO
05/16/17
UPGRADE
Target $72
MSCO
Overweight
AIG upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Kai Pan upgraded AIG to Overweight and increased its price target to $72 from $70 due to the "strong" new CEO and attractive valuation. The analyst said new CEO Brian Duperreault is an industry veteran with a strong track record that can drive sustainable and profitable growth.

TODAY'S FREE FLY STORIES

GOOG

Alphabet

$910.67

-0.31 (-0.03%)

, GOOGL

Alphabet Class A

$926.18

-1.48 (-0.16%)

16:32
08/19/17
08/19
16:32
08/19/17
16:32
Periodicals
Google working on new tools to boost news subscriptions, WSJ reports »

Google is said to be…

GOOG

Alphabet

$910.67

-0.31 (-0.03%)

GOOGL

Alphabet Class A

$926.18

-1.48 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

SRE

Sempra Energy

$116.55

0.76 (0.66%)

, BRK.A

Berkshire Hathaway

$267,377.00

302 (0.11%)

16:27
08/19/17
08/19
16:27
08/19/17
16:27
Periodicals
Sempra Energy is third bidder for Oncor Electric, Bloomberg reports »

Sempra Energy (SRE) is…

SRE

Sempra Energy

$116.55

0.76 (0.66%)

BRK.A

Berkshire Hathaway

$267,377.00

302 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

AAP

Advance Auto Parts

$93.26

0.41 (0.44%)

16:20
08/19/17
08/19
16:20
08/19/17
16:20
Periodicals
Advance Auto Parts hit wall on Q2 results, but turnaround intact, Barron's says »

In a follow up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$34.38

-13.32 (-27.92%)

, AAP

Advance Auto Parts

$93.26

0.41 (0.44%)

16:13
08/19/17
08/19
16:13
08/19/17
16:13
Periodicals
Retail stocks swings could provide opportunity, Barron's says »

This earnings season,…

FL

Foot Locker

$34.38

-13.32 (-27.92%)

AAP

Advance Auto Parts

$93.26

0.41 (0.44%)

LB

L Brands

$36.20

-1.35 (-3.60%)

URBN

Urban Outfitters

$19.27

0.33 (1.74%)

ROST

Ross Stores

$59.02

5.69 (10.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$32.67

-0.28 (-0.85%)

, BMY

Bristol-Myers

$56.42

-0.35 (-0.62%)

16:05
08/19/17
08/19
16:05
08/19/17
16:05
Periodicals
Pharmaceutical companies not the only ones with healthy dividends, Barron's says »

Most income investors are…

PFE

Pfizer

$32.67

-0.28 (-0.85%)

BMY

Bristol-Myers

$56.42

-0.35 (-0.62%)

CAH

Cardinal Health

$64.38

-0.78 (-1.20%)

PDCO

Patterson Companies

$36.45

-0.31 (-0.84%)

RMD

ResMed

$73.07

0.28 (0.38%)

ABC

AmerisourceBergen

$78.60

-1.34 (-1.68%)

UNH

UnitedHealth

$190.82

-1.88 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 27

    Aug

  • 28

    Aug

  • 06

    Sep

  • 08

    Sep

  • 08

    Sep

  • 11

    Sep

  • 11

    Sep

  • 13

    Sep

  • 18

    Sep

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 09

    Nov

  • 05

    Mar

GDI

Gardner Denver

$21.97

-0.03 (-0.14%)

, KKR

KKR

$18.14

0.11 (0.61%)

15:54
08/19/17
08/19
15:54
08/19/17
15:54
Periodicals
Gardner Denver integrated strategy beginning to pay off, Barron's says »

Under KKR (KKR), who…

GDI

Gardner Denver

$21.97

-0.03 (-0.14%)

KKR

KKR

$18.14

0.11 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSI

Motorola Solutions

$87.37

0.24 (0.28%)

, T

AT&T

$37.37

-0.23 (-0.61%)

15:47
08/19/17
08/19
15:47
08/19/17
15:47
Periodicals
Public-safety broadband network may supplant Motorola systems, Barron's says »

FirstNet has tapped…

MSI

Motorola Solutions

$87.37

0.24 (0.28%)

T

AT&T

$37.37

-0.23 (-0.61%)

CCI

Crown Castle

$104.12

-0.02 (-0.02%)

SBAC

SBA Communications

$142.90

0.69 (0.49%)

AMT

American Tower

$140.00

0.35 (0.25%)

COMM

CommScope

$33.00

0.16 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 06

    Sep

LMT

Lockheed Martin

$299.20

-2.22 (-0.74%)

15:39
08/19/17
08/19
15:39
08/19/17
15:39
Periodicals
Lockheed Martin should benefit from boost in military outlays, Barron's says »

Large-cap defense stocks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

SBUX

Starbucks

$52.70

-0.34 (-0.64%)

15:26
08/19/17
08/19
15:26
08/19/17
15:26
Periodicals
Starbucks could jump 20%, Barron's says »

There were plenty of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 02

    Nov

  • 25

    Jan

MRK

Merck

$61.49

-0.35 (-0.57%)

, INTC

Intel

$35.01

-0.16 (-0.45%)

15:05
08/19/17
08/19
15:05
08/19/17
15:05
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

MRK

Merck

$61.49

-0.35 (-0.57%)

INTC

Intel

$35.01

-0.16 (-0.45%)

UA

Under Armour

$15.64

-0.64 (-3.93%)

UAA

Under Armour

$17.12

-0.69 (-3.87%)

CPB

Campbell Soup

$53.69

-0.27 (-0.50%)

JNJ

Johnson & Johnson

$132.63

-0.41 (-0.31%)

UTX

United Technologies

$115.48

-0.62 (-0.53%)

BX

Blackstone

$31.52

-0.08 (-0.25%)

JPM

JPMorgan

$90.74

0.09 (0.10%)

GM

General Motors

$34.83

-0.17 (-0.49%)

WMT

Wal-Mart

$79.31

-0.39 (-0.49%)

TSLA

Tesla

$347.46

-4.46 (-1.27%)

DIS

Disney

$100.70

-0.68 (-0.67%)

AMZN

Amazon.com

$958.47

-2.1 (-0.22%)

AET

Aetna

$154.45

-1.36 (-0.87%)

ANTM

Anthem

$191.02

-0.94 (-0.49%)

CNC

Centene

$83.49

-0.13 (-0.16%)

CI

Cigna

$177.03

-1 (-0.56%)

HNT

Health Net

HUM

Humana

$247.28

-0.38 (-0.15%)

MOH

Molina Healthcare

$59.63

0.12 (0.20%)

UNH

UnitedHealth

$190.82

-1.88 (-0.98%)

WCG

WellCare

$173.56

-2.2 (-1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 24

    Aug

  • 26

    Aug

  • 28

    Aug

  • 29

    Aug

  • 31

    Aug

  • 05

    Sep

  • 06

    Sep

  • 07

    Sep

  • 08

    Sep

  • 11

    Sep

  • 12

    Sep

  • 22

    Sep

  • 22

    Sep

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 12

    Oct

  • 08

    Nov

  • 16

    Nov

  • 20

    Feb

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

CTL

CenturyLink

$19.16

-0.22 (-1.14%)

, LVLT

Level 3

$52.69

-0.3 (-0.57%)

14:52
08/19/17
08/19
14:52
08/19/17
14:52
Hot Stocks
CenturyLink continues to expect acquisition of Level 3 to be complete by Q3 »

CenturyLink (CTL) said in…

CTL

CenturyLink

$19.16

-0.22 (-1.14%)

LVLT

Level 3

$52.69

-0.3 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

$105.80

-0.07 (-0.07%)

17:45
08/18/17
08/18
17:45
08/18/17
17:45
Hot Stocks
Kansas City Southern director Henry Maier buys 3,000 shares »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

RXII

RXi Pharmaceuticals

$0.58

-0.02 (-3.36%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on RXi Pharmaceuticals »

RXi Pharmaceuticals files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WIN

Windstream

$1.98

0.06 (3.13%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Hot Stocks
Windstream CEO acquires 25,381 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$2.44

-0.22 (-8.27%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on CEL-SCI »

CEL-SCI files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRN

Trinity Industries

$28.20

-0.03 (-0.11%)

17:25
08/18/17
08/18
17:25
08/18/17
17:25
Hot Stocks
ValueAct raises stake inTrinity Industries to 11% from 9.8% »

As of this date, ValueAct…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPTN

Lpath

17:11
08/18/17
08/18
17:11
08/18/17
17:11
Hot Stocks
Breaking Hot Stocks news story on Lpath »

Stonepine Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGR

Progressive

$48.63

0.12 (0.25%)

17:08
08/18/17
08/18
17:08
08/18/17
17:08
Hot Stocks
Progressive CFO sells 50,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$172.57

-0.32 (-0.19%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Thermo Fisher director sells 11,318 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

SMBC

Southern Missouri Bancorp

$31.18

-0.05 (-0.16%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Southern Missouri Bancorp and Southern Missouri Bancshares to merge »

Southern Missouri Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:58
08/18/17
08/18
16:58
08/18/17
16:58
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ended advisory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says never had…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:56
08/18/17
08/18
16:56
08/18/17
16:56
Hot Stocks
Icahn no longer special advisor to President Trump on regulatory reform issues »

Carl Icahn, founder of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:55
08/18/17
08/18
16:55
08/18/17
16:55
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.